| Primary |
| Rheumatoid Arthritis |
19.6% |
| Burkitt's Lymphoma |
6.5% |
| Sedation |
6.5% |
| Gastrooesophageal Reflux Disease |
5.4% |
| Influenza |
5.4% |
| Oesophagitis |
5.4% |
| Arrhythmia |
4.3% |
| Dyslipidaemia |
4.3% |
| Hypertension |
4.3% |
| Hypothyroidism |
4.3% |
| Product Used For Unknown Indication |
4.3% |
| Arthritis |
3.3% |
| Arthropathy |
3.3% |
| Atrial Fibrillation |
3.3% |
| Diarrhoea |
3.3% |
| Duodenitis |
3.3% |
| Essential Hypertension |
3.3% |
| Gastritis |
3.3% |
| Lung Disorder |
3.3% |
| Meningitis Staphylococcal |
3.3% |
|
| Neutropenia |
11.6% |
| Pancytopenia |
10.1% |
| Agranulocytosis |
8.7% |
| Vomiting |
8.7% |
| Renal Failure Acute |
7.2% |
| Thrombocytopenia |
7.2% |
| Pancreatitis Acute |
5.8% |
| Purpura |
4.3% |
| Splenic Infarction |
4.3% |
| Burning Sensation |
2.9% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.9% |
| Gingival Cancer |
2.9% |
| Hyponatraemia |
2.9% |
| Inappropriate Antidiuretic Hormone Secretion |
2.9% |
| Liver Disorder |
2.9% |
| Mitral Valve Incompetence |
2.9% |
| Pancreatitis |
2.9% |
| Pneumonia Aspiration |
2.9% |
| Rash |
2.9% |
| Renal Failure |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
62.5% |
| Drug Use For Unknown Indication |
5.6% |
| Infection |
3.6% |
| Hypertension |
3.0% |
| Pyrexia |
2.8% |
| Burkitt's Lymphoma |
2.6% |
| Rheumatoid Arthritis |
2.5% |
| Prophylaxis |
1.8% |
| Atrial Fibrillation |
1.5% |
| Arthropathy |
1.4% |
| Epilepsy |
1.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.4% |
| Prophylaxis Against Transplant Rejection |
1.4% |
| Adrenocortical Carcinoma |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Diarrhoea |
1.3% |
| Cardiac Failure |
1.2% |
| Helicobacter Infection |
1.2% |
| Hypercholesterolaemia |
1.2% |
| Chemotherapy |
1.1% |
|
| Pancytopenia |
10.3% |
| Thrombocytopenia |
10.3% |
| Pancreatitis |
6.8% |
| Toxic Skin Eruption |
6.0% |
| Transaminases Increased |
6.0% |
| Vomiting |
6.0% |
| Pancreatitis Acute |
5.1% |
| Purpura |
5.1% |
| Inappropriate Antidiuretic Hormone Secretion |
4.3% |
| Pneumonia |
4.3% |
| Rash |
4.3% |
| Renal Failure Acute |
4.3% |
| Thrombocytopenic Purpura |
4.3% |
| Agranulocytosis |
3.4% |
| Cytolytic Hepatitis |
3.4% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
3.4% |
| Hepatocellular Injury |
3.4% |
| Rash Maculo-papular |
3.4% |
| Toxic Epidermal Necrolysis |
3.4% |
| Bicytopenia |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
41.0% |
| Drug Use For Unknown Indication |
11.7% |
| Rheumatoid Arthritis |
7.2% |
| Hypertension |
4.9% |
| Pain |
4.1% |
| Atrial Fibrillation |
3.2% |
| Prophylaxis |
3.1% |
| Pancreatic Carcinoma |
2.5% |
| Depression |
2.3% |
| Anxiety |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Staphylococcal Infection |
2.1% |
| Plasma Cell Myeloma |
1.9% |
| Premedication |
1.9% |
| Renal Transplant |
1.9% |
| Tuberculosis |
1.8% |
| B-cell Lymphoma |
1.7% |
| Pulmonary Arterial Hypertension |
1.6% |
| Colorectal Cancer Metastatic |
1.5% |
| Thrombosis Prophylaxis |
1.5% |
|
| Vomiting |
17.6% |
| Renal Failure Acute |
10.3% |
| Renal Failure |
9.6% |
| Weight Decreased |
7.4% |
| Somnolence |
6.6% |
| Thrombocytopenia |
5.9% |
| Sepsis |
4.4% |
| Agranulocytosis |
2.9% |
| Cholestasis |
2.9% |
| Drug Ineffective |
2.9% |
| Hyponatraemia |
2.9% |
| Interstitial Lung Disease |
2.9% |
| Metastases To Liver |
2.9% |
| Oedema Peripheral |
2.9% |
| Overdose |
2.9% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.9% |
| Pancreatitis Acute |
2.9% |
| Pancytopenia |
2.9% |
| Peripheral Sensory Neuropathy |
2.9% |
| Pyrexia |
2.9% |
|
| Interacting |
| Pain |
21.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
21.4% |
| Pulmonary Arterial Hypertension |
21.4% |
| Endotracheal Intubation |
17.9% |
| Premedication |
10.7% |
| Bronchial Carcinoma |
7.1% |
|
| Tracheal Haemorrhage |
37.5% |
| Anaemia |
25.0% |
| Drug Interaction |
25.0% |
| Subdural Haematoma |
12.5% |
|
